Pictet Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Buy
9,150
+553
+6% +$119K 2.47% 13
2026
Q1
$1.87M Sell
8,597
-291
-3% -$64.6K 2.46% 13
2025
Q4
$2.03M Buy
8,888
+1,956
+28% +$446K 2.44% 16
2025
Q3
$1.61M Buy
+6,932
New +$1.41M 1.93% 20

Other funds holding ABBV

Pictet Bank & Trust's ABBV Position: Q2 2026 in Review

Pictet Bank & Trust increased its AbbVie (ABBV) stake by 6.4% in Q2 2026, buying an estimated $119K and bringing the position to 9,150 shares worth $2.3M. The position accounts for 2.47% of the portfolio, ranked #13.

Pictet Bank & Trust first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pictet Bank & Trust held 9,150 shares of AbbVie worth $2.3M as of Q2 2026.
  • Pictet Bank & Trust bought 553 AbbVie shares in Q2 2026, an estimated $119K.
  • AbbVie made up 2.47% of Pictet Bank & Trust's portfolio in Q2 2026, its #13 holding.
  • Pictet Bank & Trust first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pictet Bank & Trust's 13F filing for Q2 2026, filed 24 Jul 2026.